Study: Rahbari-Oskoui 2019, Complementary Therapies in Medicine

Nighttime administration of high-dose, sustained-release melatonin does not decrease nocturnal blood pressure in African-American patients: Results from a preliminary randomized, crossover trial

Citation

Rahbari-Oskoui FF, Abramson JL, Bruckman AM, Chapman AB et al (2019). Complementary Therapies in Medicine. PubMed id 30935524.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Melatonin for sleep: what it does, dose and rules by country Tier B thin

    A Self-defined African American patients with essential hypertension, urban academic medical centre, United States (n=40)

    Randomised, placebo-controlled crossover pilot: 24 mg sustained-release melatonin at night against placebo, 4 weeks each.

    Night-time and daytime blood pressure on 24-hour monitoring did not differ between melatonin and placebo. The authors note this contrasts with studies in other populations.

    As recorded in this card: Rahbari-Oskoui FF, Abramson JL, Bruckman AM, Chapman AB et al (2019), Complementary Therapies in Medicine, [primary]

    Note: A trial in Black participants, but its outcome was blood pressure, with sleep unmeasured, at a dose far above the usual one. The registry lists a second 8 mg study (NCT01114360, 37 people, results posted) that I did not read.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.